Prevail Therapeutics Inc (PRVL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 168,051 | 63,014 |
| TOTAL | $174,461 | $63,577 |
| Non-Current Assets | ||
| PPE Net | 2,549 | 678 |
| Other Non-Current Assets | 10,092 | 8,625 |
| TOTAL | $12,641 | $9,303 |
| Total Assets | $187,102 | $72,880 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 5,162 | 1,241 |
| Accrued Expenses | 5,330 | 1,477 |
| TOTAL | $11,833 | $3,635 |
| Non-Current Liabilities | ||
| Other Non-Current Liabilities | 9,927 | 7,952 |
| TOTAL | $9,927 | $7,952 |
| Total Liabilities | $21,760 | $11,587 |
| Shareholders' Equity | ||
| Shares Outstanding, K | 34,171 | N/A |
| Common Shares | 3 | 1 |
| Retained earnings | -84,102 | -20,914 |
| TOTAL | $165,342 | $61,293 |
| Total Liabilities And Equity | $187,102 | $72,880 |